Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Geraldine Tierney

ROS1 Rearrangements Are Only Found in Lung Adenocarcinomas With Diffuse Strong IHC Expression of ROS1

Pathology

Forensic Medicine

Pathology

2020

English

Related publications

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peri-Diagnosis Thromboembolic Events

Journal of Thoracic Oncology

English

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: The ROSING Study

Journal of Thoracic Oncology

English

P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients

Journal of Thoracic Oncology

English

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

Journal of Thoracic Oncology

English

Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent in Situ Hybridization: The Importance of Probe Design

Journal of Thoracic Oncology

English

Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients

Cancer Biology and Therapy

English

P1.09-12 Simultaneous Platform of Genotyping EGFR, ALK, and ROS1 in Patients With NSCLC Highlights Correlation of ROS1 and PD-L1 Expression

Journal of Thoracic Oncology

English

P2.09-13 Correlation of ROS1 (SP384) Immunohistochemistry With ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization

Journal of Thoracic Oncology

English

Expression of C-Terminal ALK, RET, or ROS1 in Lung Cancer Cells With or Without Fusion

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Geraldine Tierney

ROS1 Rearrangements Are Only Found in Lung Adenocarcinomas With Diffuse Strong IHC Expression of ROS1

Related publications

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peri-Diagnosis Thromboembolic Events

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: The ROSING Study

P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent in Situ Hybridization: The Importance of Probe Design

Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients

P1.09-12 Simultaneous Platform of Genotyping EGFR, ALK, and ROS1 in Patients With NSCLC Highlights Correlation of ROS1 and PD-L1 Expression

P2.09-13 Correlation of ROS1 (SP384) Immunohistochemistry With ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization

Expression of C-Terminal ALK, RET, or ROS1 in Lung Cancer Cells With or Without Fusion